GLP-1 Weight Loss Plateau: Why Your Progress May Slow Down

A slower number on the scale doesn’t necessarily mean your GLP-1 treatment has stopped working.

One of the most frustrating moments during weight management is when the scale suddenly stops moving.

You may have been losing weight consistently for several weeks or months, only to find that your weight stays almost the same despite continuing treatment and making similar lifestyle choices.

This is often called a weight loss plateau.

For people using GLP-1-based treatment, a plateau can create understandable questions:

“Has the medication stopped working?”

“Do I need a higher dose?”

“Am I doing something wrong?”

“Why was I losing weight before but not now?”

The answer is not always a change in medication.

Clinical research shows that weight loss often follows a pattern: substantial reduction early in treatment, followed by a period where weight loss slows and eventually stabilises. In the two-year STEP 5 trial, weight loss with semaglutide was substantial initially and plateaued at approximately week 60 before remaining relatively stable through week 104.

Understanding why this happens can help patients set more realistic expectations and decide when a medical review may actually be useful.

What Is a GLP-1 Weight Loss Plateau?

A weight loss plateau occurs when your body weight remains relatively stable for a period despite continuing with your weight-management plan.

It does not necessarily mean that all progress has stopped.

Your weight can fluctuate from day to day because of:

• Fluid retention
• Food intake
• Bowel movements
• Sodium intake
• Hormonal changes
• Exercise
• Sleep

Therefore, a few days without a change on the scale is not necessarily a true plateau.

A longer period of stable weight is more meaningful and may be worth discussing with your healthcare provider.

Why Does Weight Loss Slow Down?

There are several reasons weight loss can become slower over time.

Your Body Needs Fewer Calories at a Lower Weight

As your body becomes lighter, it generally requires less energy to maintain itself.

This means that the calorie deficit that produced weight loss at the beginning may become smaller as your weight decreases.

The NIDDK explains that metabolism slows during weight loss and that the body requires fewer calories at a lower weight. This can make maintaining or continuing weight loss more difficult.

This is a normal physiological response, not necessarily a sign that treatment has failed.

Your Early Weight Loss May Have Included Fluid Changes

Weight can fall relatively quickly at the beginning of a weight-loss programme.

Part of the early change may reflect shifts in body water as food intake and carbohydrate intake change.

Later weight changes may be slower because the rate of these initial changes decreases.

This can make the first few weeks look very different from the following months.

What Did the STEP 5 Trial Show?

The STEP 5 trial followed adults with overweight or obesity without diabetes for 104 weeks.

Participants received either once-weekly semaglutide 2.4 mg or placebo, alongside behavioural intervention.

At week 104, the average change in body weight was:

• −15.2% with semaglutide
• −2.6% with placebo

The study found that weight loss was substantial during the earlier part of treatment and plateaued at approximately week 60, remaining generally stable for the rest of the two-year study.

This is an important point for patients.

A plateau can represent stabilisation after significant weight loss, rather than a sudden loss of medication effect.

The same study also found that changes in waist circumference, blood pressure, and HbA1c followed a similar pattern, with improvements generally plateauing around the same period and being maintained through week 104.

Does a Plateau Mean GLP-1 Treatment Has Stopped Working?

Not necessarily.

A medication can continue to support appetite regulation even when the number on the scale changes very little.

For example, you may notice:

• Smaller portions still feel satisfying
• Cravings remain lower
• You are maintaining your weight rather than regaining it
• Your waist circumference has changed
• Your blood pressure has improved
• Your blood sugar markers have improved

Weight maintenance can itself be an important treatment outcome.

The NIDDK notes that prescription weight-management medications work best when combined with lifestyle changes and that treatment response varies between individuals.

Everyone Responds Differently

One of the most important things to understand about GLP-1 treatment is that there is no identical response for every patient.

Two people can use the same medication and experience different:

• Appetite changes
• Side effects
• Weight loss
• Treatment timelines
• Maintenance needs

Clinical trials demonstrate average responses across groups, but those averages do not predict exactly what will happen to one individual.

The NIDDK specifically notes that weight-management medication results vary by medication and by person.

Comparing your progress with someone else’s can therefore create unrealistic expectations.

Does Dose Affect Weight Loss?

Dose can matter, but increasing medication is not automatically the answer to a plateau.

Clinical trials commonly use a gradual dose-escalation period.

For example, the SURMOUNT-1 trial studied tirzepatide at different doses over 72 weeks and included a 20-week dose-escalation period. Participants started at 2.5 mg once weekly and increased the dose in 2.5 mg increments every four weeks during the escalation period.

The trial found substantial weight reduction across the studied tirzepatide doses, but treatment also involved lifestyle intervention and individual tolerability.

This illustrates why dose and treatment duration should be considered together rather than assuming that a higher dose is always necessary.

Why Starting Dose Is Not the Same as Maintenance Dose

Patients sometimes expect the starting dose to produce the same effect as a maintenance dose.

That is not how these treatments are generally designed.

For example, the current FDA prescribing information for Wegovy injection starts treatment at 0.25 mg once weekly for four weeks, followed by gradual dose escalation every four weeks.

Similarly, the current FDA prescribing information for Zepbound recommends starting at 2.5 mg once weekly for four weeks before increasing the dose, with treatment response and tolerability considered when selecting a maintenance dose.

The purpose of gradual escalation includes helping patients adjust to treatment and reducing the risk of gastrointestinal adverse effects.

Therefore, someone who has only recently started treatment should not necessarily expect the same weight-loss pattern seen in long-term clinical trials.

Could Your Lifestyle Have Changed?

A plateau may also happen because daily habits have gradually changed.

This does not mean that you have “failed.”

Small changes can accumulate over time.

For example:

• Portions may have increased slightly
• Snacks may have returned
• Walking may have decreased
• Exercise may have become less consistent
• Weekend eating may have changed
• Alcohol intake may have increased
• Sleep may have become worse

The NIDDK identifies lifestyle habits, sleep, medications, health conditions, environment, family history, and genetics as factors that can affect weight.

A medical review can therefore be useful before assuming the medication itself is the problem.

Could Sleep Affect Your Weight?

Sleep is often overlooked during weight management.

The NIDDK notes that insufficient sleep is associated with weight gain and may increase hunger, calorie intake, and preference for less healthy foods.

If your weight has plateaued, it may be worth asking:

• Am I getting enough sleep?
• Has my sleep quality changed?
• Am I waking frequently?
• Has work or family stress increased?

For some patients, improving sleep may be an important part of the overall plan.

Could Another Medication Affect Your Weight?

Some medications can contribute to weight gain or make weight management more difficult.

The NIDDK lists several categories of medicines that may affect weight, including certain medications used for:

• Depression
• Psychotic disorders
• Epilepsy
• Diabetes
• High blood pressure
• Allergies

If your weight has changed unexpectedly, tell your doctor about all medications and supplements you are taking.

Do not stop another prescribed medication simply because you think it may be affecting your weight.

Could a Health Condition Be Affecting Your Progress?

Medical conditions can also influence weight.

Examples identified by the NIDDK include:

• Polycystic ovary syndrome (PCOS)
• Hypothyroidism
• Cushing’s syndrome
• Depression
• Long-term stress

If your weight has stopped changing despite consistent treatment and lifestyle habits, a doctor may consider whether another health factor needs to be assessed.

Should You Increase Your GLP-1 Dose During a Plateau?

Not automatically.

Increasing a dose simply because the scale has stopped moving may expose you to additional side effects without addressing the underlying reason for the plateau.

Your doctor may first consider:

• How long you have been at your current dose
• Appetite control
• Side effects
• Nutrition
• Physical activity
• Sleep
• Other medications
• Medical conditions
• Weight trend over time

The FDA prescribing information for Zepbound specifically states that treatment response and tolerability should be considered when selecting the maintenance dosage.

Dose changes should therefore be made as part of medical treatment, not based solely on the number displayed on the scale.

What Should You Do During a Weight Loss Plateau?

Before assuming that treatment has failed, look at the bigger picture.

Review Your Food Intake

Ask whether your portion sizes, snacks, drinks, or eating patterns have changed.

Prioritise Protein and Nutrient-Dense Foods

Adequate nutrition remains important during weight loss, particularly when appetite is reduced.

Stay Physically Active

Regular physical activity supports both weight management and overall health.

The NIDDK recommends combining aerobic activity with muscle-strengthening activity where appropriate.

Check Your Sleep

Poor sleep may make appetite and food choices more difficult to manage.

Look Beyond the Scale

Consider changes in:

• Waist circumference
• Clothing fit
• Strength
• Blood pressure
• Blood sugar
• Energy
• Overall health

When Should You Speak to Your Doctor?

A plateau is not necessarily an emergency, but it can be a good reason for a treatment review if it continues or if other concerns appear.

Speak with your doctor if:

• Your appetite has significantly returned
• You are experiencing troublesome side effects
• Your weight is increasing again
• You are struggling to maintain adequate nutrition
• Your treatment no longer seems appropriate
• You are considering changing your dose
• You have developed new symptoms

A review can help determine whether the current treatment should continue, change, or simply be given more time.

What a Doctor May Assess

A doctor-led weight-management review may include:

• Weight trend rather than a single measurement
• BMI
• Waist circumference
• Appetite and cravings
• Diet and physical activity
• Sleep
• Blood pressure
• Current medications
• Medical history
• HbA1c or blood glucose
• Cholesterol
• Liver and kidney function when appropriate
• Treatment response
• Side effects
• Medication suitability

This helps identify whether you are experiencing a normal plateau or whether something else needs attention.

Benefits and Key Points to Understand

A weight loss plateau can be frustrating, but it is not necessarily a sign that your GLP-1 treatment has stopped working.

The key points are:

• Weight loss commonly slows over time
• The body needs fewer calories at a lower weight
• STEP 5 observed a weight-loss plateau at approximately week 60
• Weight can remain stable after substantial weight reduction
• Individual responses vary
• Dose escalation is gradual for commonly used treatments
• Lifestyle factors continue to matter
• Sleep, medications, genetics, and health conditions can affect weight
• Treatment decisions should consider more than the scale

A slower rate of weight loss can be part of the expected treatment pattern.

Safety and Important Considerations

GLP-1 and related weight-management medications can cause side effects, particularly gastrointestinal symptoms.

These may include:

• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Abdominal discomfort

In the STEP 5 trial, gastrointestinal adverse events were more common with semaglutide than placebo and were generally mild to moderate.

The SURMOUNT-1 trial similarly reported gastrointestinal adverse events as the most common adverse events with tirzepatide, occurring primarily during dose escalation.

Patients should not change medication doses, combine treatments, or stop prescription treatment without discussing it with their healthcare provider.

Why Doctor-Led Care Matters

A plateau is not a diagnosis.

It is a reason to look at the whole treatment picture.

Sometimes the appropriate response is simply to continue with the current plan. Sometimes lifestyle factors need attention. In other cases, a doctor may identify a medical condition, medication issue, side effect, or treatment-related factor that needs to be addressed.

The important thing is not to make a decision based on the scale alone.

Weight Management Consultation in Bangkok

If your weight has plateaued during GLP-1 treatment, MedConsult Clinic can help you review what may be happening.

A consultation can look at your weight trend, appetite, lifestyle, medical history, current treatment, and relevant health markers.

The goal is to understand whether your current progress is within an expected pattern and whether any part of your treatment plan needs to be reviewed.

Not every plateau means you need a higher dose. Sometimes, understanding the reason for the plateau is the most useful next step.

weight management treatment in Bangkok

tirzepatide side effects

weight loss medication in Thailand

Mounjaro in Thailand

medical weight-management consultation